NEU 2.81% $18.65 neuren pharmaceuticals limited

Removal of $3 prop, page-60

  1. 669 Posts.
    lightbulb Created with Sketch. 60
    The main reason for the fall was because the company applied for breakthrough and it failed not because of the trial failed
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.